Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 22, 1999

View Archived Issues

Interneuron: FY 1998 results

MorphoSys enters licensing agreement with Chiron for HuCAL

Actinova enters collaboration for development of tooth decay treatment

Results of animal studies indicate ability of GeneSwitch to regulate gene therapy

Chugai presents new COX-2 inhibitor series

Compounds for depression and other CNS disorders reported by Akzo Nobel

Improved treatments for BPH in development at Pfizer

Novel squalene synthase inhibitors claimed by Nippon Kayaku

Several setbacks reported with Lundbeck antipsychotic

Integrin receptor antagonists, prodrugs and transdermal iontophoretic administration

Medeva launches Anthra's valrubicin in first market

Unigene obtains E.U. approval for injectable calcitonin product

Bayer claims camptothecin glycoconjugates for use in cancer

Potent and selective DAT ligand identified by RTI and Emory University

Rochester Medical files PMA for FemSoft

Telmisartan reaches U.S. pharmacy shelves

Terprenin: novel immunosuppressant and antiallergic substance under evaluation at Shionogi

FDA grants priority review to SB's Avandia

Japanese group discovers novel microbial metabolite with antitumor and immunosuppressive effects

Cel-Sci and University of Maryland receive award for TB vaccine development

Genzyme collaborates with Canadian researchers to develop cardiovascular disease therapies

Mitsubishi Chemical and Tokyo Tanabe to merge

Vertex initiates phase II psoriasis trial of VX-497

Snow Brand reports new developments concerning cevimeline

Avant receives patent coverage for complement inhibitors

Celebrex approved in first market outside U.S.

PAP mutants licensed by Hughes Institute; potential anticancer and antiviral therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...